Analysis of the T-Cell Subsets' Purity
Patients . | Cell Populations . | Contaminating Cells (%) . | ||||
---|---|---|---|---|---|---|
. | . | CD4+ . | CD8+ . | CD57+ . | CD4+CD57+ . | CD8+CD57+ . |
ROPI | CD4+CD57− | — | 1.9 | 0.7 | — | 0.2 |
CD4−CD57− | 6.5 | — | 20.5 | 0.2 | — | |
GEGU | CD4+CD57− | — | 1.2 | 1.1 | — | 0.2 |
CD4−CD57− | 5.4 | — | 20.7 | 0.1 | — | |
LOME | CD4+CD57− | — | 1.9 | 0.5 | — | 0.1 |
CD4−CD57− | 5.7 | — | 14.7 | 0.1 | — | |
MAGHI | CD4+CD57− | — | 2.2 | 2.7 | — | 0.3 |
CD4−CD57− | 1.6 | — | 17.2 | 0.0 | — |
Patients . | Cell Populations . | Contaminating Cells (%) . | ||||
---|---|---|---|---|---|---|
. | . | CD4+ . | CD8+ . | CD57+ . | CD4+CD57+ . | CD8+CD57+ . |
ROPI | CD4+CD57− | — | 1.9 | 0.7 | — | 0.2 |
CD4−CD57− | 6.5 | — | 20.5 | 0.2 | — | |
GEGU | CD4+CD57− | — | 1.2 | 1.1 | — | 0.2 |
CD4−CD57− | 5.4 | — | 20.7 | 0.1 | — | |
LOME | CD4+CD57− | — | 1.9 | 0.5 | — | 0.1 |
CD4−CD57− | 5.7 | — | 14.7 | 0.1 | — | |
MAGHI | CD4+CD57− | — | 2.2 | 2.7 | — | 0.3 |
CD4−CD57− | 1.6 | — | 17.2 | 0.0 | — |